Front Neurosci. 2017 Jun 02;11:317. doi: 10.3389/fnins.2017.00317. eCollection 2017.
Frontiers in neuroscience
Simon C Drew
PMID: 28626387 PMCID: PMC5455140 DOI: 10.3389/fnins.2017.00317
The "therapeutic chelation" approach to treating Alzheimer's disease (AD) evolved from the metals hypothesis, with the premise that small molecules can be designed to prevent transition metal-induced amyloid deposition and oxidative stress within the AD brain. Over more than 20 years, countless
Keywords: Alzheimer's disease; N-truncation; bioinorganic chemistry; chelator; copper; metal homeostasis; metals hypothesis; β-amyloid